Show simple item record

dc.contributor.authorTomlinson, OW
dc.contributor.authorMarkham, L
dc.contributor.authorWollerton, RL
dc.contributor.authorKnight, BA
dc.contributor.authorDuckworth, A
dc.contributor.authorSpiers, A
dc.contributor.authorWilliams, CA
dc.contributor.authorGibbons, M
dc.contributor.authorScotton, CJ
dc.date.accessioned2019-11-21T14:57:11Z
dc.date.issued2019-11-12
dc.description.abstractCardiopulmonary exercise testing (CPET) isshown to befeasible in patients with interstitial lung disease (ILD), highlighting its prospective use as an outcome measure for prognostic monitoring. However, validity and reproducibility, in terms of eliciting maximal exercise and identifying significant changes over time remain unknown.en_GB
dc.identifier.citationVol. 74 (supplement 2), article A90en_GB
dc.identifier.doi10.1136/thorax-2019-btsabstracts2019.147
dc.identifier.urihttp://hdl.handle.net/10871/39689
dc.language.isoenen_GB
dc.publisherBMJ Publishing Group Ltd and British Thoracic Societyen_GB
dc.rights© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.en_GB
dc.titleValidity and reproducibility of cardiopulmonary exercise testing in interstitial lung diseaseen_GB
dc.typeArticleen_GB
dc.date.available2019-11-21T14:57:11Z
dc.identifier.issn1468-3296
dc.descriptionThis is the author accepted manuscript. The final version is available from BMJ Publishing Group via the DOI in this recorden_GB
dc.descriptionBritish Thoracic Society Winter Meeting 2019, London, 4 - 6 December 2019
dc.identifier.journalThoraxen_GB
dc.rights.urihttp://www.rioxx.net/licenses/all-rights-reserveden_GB
rioxxterms.versionAMen_GB
rioxxterms.licenseref.startdate2019-11-12
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2019-11-21T14:54:23Z
refterms.versionFCDAM
refterms.dateFOA2019-11-21T14:57:17Z
refterms.panelCen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record